Alexion Pharmaceuticals
Czura Holly is an experienced professional in clinical operations and project management with a strong focus on Southeast Asia and Taiwan. Currently serving as Associate Director, Study Lead Country Operations at Alexion Pharmaceuticals, Inc. since June 2018, Czura is responsible for coordinating activities among Country Operations Management teams and global study teams, contributing to patient recruitment strategies, and leading site start-up efforts. Previous roles include Associate Director positions at Alexion, clinical research management roles at Celgene and Novartis, and clinical trial coordination at StatPlus, Inc. and National Taiwan Hospital. Czura has a proven track record of exceeding performance expectations and ensuring quality compliance in clinical trials, with extensive experience spanning various therapeutic areas and phases of study.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.